Author: kwm107
-
Study Reveals Potential Therapeutic Target for Genetic Liver Disease
Northwestern Medicine investigators have discovered the molecular mechanisms underlying a rare genetic disorder that increases the risk of severe liver disease, according to a recent study.
-
2021 Year in Review
Feinberg experienced a year of exceptional growth, perseverance, and collaboration in 2021, from honors and awards to unprecedented research discoveries.
-
First Model to Predict Lifetime Risk of Heart Failure
A new Northwestern Medicine study has, for the first time, derived and validated a set of risk prediction models for lifetime risk of heart failure.
-
Ophthalmology Receives Grant to Support International Collaboration
Steven DeVries, MD, PhD, has received a $75,000 International Research Collaborators Award from Research to Prevent Blindness to support international collaborations.
-
Northwestern Selected as Home for Journal of Clinical Investigation; McNally to Serve as Editor-in-Chief
Northwestern University Feinberg School of Medicine has been selected to serve as the home of the Journal of Clinical Investigation for its next five-year term, and Elizabeth McNally, MD, PhD, has been elected as the journal’s next editor-in-chief.
-
A Day in the Life: Medical Student Zach Cross
Follow along with a typical day in the life of third-year Feinberg medical student, as he spends a shift in the OB-GYN ward, including assisting with a delivery.
-
ALS Therapy Should Target Brain, Not Just Spine
A new study has shown that the degeneration of brain motor neurons in ALS is not merely a byproduct of the spinal motor neuron degeneration, and is a target for future treatments for the disease.
-
Cella to Step Down as Chair of Medical Social Sciences
David Cella, PhD, the Ralph Seal Paffenbarger Professor, has announced that he will be stepping down as chair of the Department of Medical Social Sciences, the department he helped establish in 2009.
-
Predicting Which Glioblastoma Patients Will Respond to Immunotherapy
Northwestern Medicine scientists have discovered a new biomarker to identify which patients with brain tumors called glioblastomas — the most common and malignant of primary brain tumors — might benefit from immunotherapy.
-
$12.5 Million to Fund ALS Research at Northwestern
Neurodegenerative Disease Research Inc. has made a five-year, $12.5 million philanthropic commitment to Northwestern to support research in amyotrophic lateral sclerosis (ALS) led by Teepu Siddique, MD.
